Anthony M. Giannetti, Ph.D. - Publications

Affiliations: 
California Institute of Technology, Pasadena, CA 
Area:
cell surface recognition

12/43 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Yamniuk AP, Newitt JA, Doyle ML, Arisaka F, Giannetti AM, Hensley P, Myszka DG, Schwarz FP, Thomson JA, Eisenstein E. Development of a Model Protein Interaction Pair as a Benchmarking Tool for the Quantitative Analysis of 2-Site Protein-Protein Interactions. Journal of Biomolecular Techniques : Jbt. PMID 26543437 DOI: 10.7171/Jbt.15-2604-001  0.339
2011 Giannetti AM, Wong H, Dijkgraaf GJ, Dueber EC, Ortwine DF, Bravo BJ, Gould SE, Plise EG, Lum BL, Malhi V, Graham RA. Identification, characterization, and implications of species-dependent plasma protein binding for the oral Hedgehog pathway inhibitor vismodegib (GDC-0449). Journal of Medicinal Chemistry. 54: 2592-601. PMID 21438527 DOI: 10.1021/Jm1008924  0.318
2009 Hang JQ, Yang Y, Harris SF, Leveque V, Whittington HJ, Rajyaguru S, Ao-Ieong G, McCown MF, Wong A, Giannetti AM, Le Pogam S, Talamás F, Cammack N, Nájera I, Klumpp K. Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of hepatitis C virus. The Journal of Biological Chemistry. 284: 15517-29. PMID 19246450 DOI: 10.1074/Jbc.M808889200  0.398
2008 Schmidt PJ, Toran PT, Giannetti AM, Bjorkman PJ, Andrews NC. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metabolism. 7: 205-14. PMID 18316026 DOI: 10.1016/J.Cmet.2007.11.016  0.592
2006 Byrne SL, Leverence R, Klein JS, Giannetti AM, Smith VC, MacGillivray RT, Kaltashov IA, Mason AB. Effect of glycosylation on the function of a soluble, recombinant form of the transferrin receptor. Biochemistry. 45: 6663-73. PMID 16716077 DOI: 10.1021/Bi0600695  0.523
2005 Halbrooks PJ, Giannetti AM, Klein JS, Björkman PJ, Larouche JR, Smith VC, MacGillivray RT, Everse SJ, Mason AB. Composition of pH-sensitive triad in C-lobe of human serum transferrin. Comparison to sequences of ovotransferrin and lactoferrin provides insight into functional differences in iron release. Biochemistry. 44: 15451-60. PMID 16300393 DOI: 10.1021/Bi0518693  0.633
2005 Giannetti AM, Halbrooks PJ, Mason AB, Vogt TM, Enns CA, Björkman PJ. The molecular mechanism for receptor-stimulated iron release from the plasma iron transport protein transferrin Structure. 13: 1613-1623. PMID 16271884 DOI: 10.1016/J.Str.2005.07.016  0.651
2004 Giannetti AM, Björkman PJ. HFE and transferrin directly compete for transferrin receptor in solution and at the cell surface Journal of Biological Chemistry. 279: 25866-25875. PMID 15056661 DOI: 10.1074/Jbc.M401467200  0.68
2003 Giannetti AM, Snow PM, Zak O, Björkman PJ. Mechanism for multiple ligand recognition by the human transferrin receptor. Plos Biology. 1: E51. PMID 14691533 DOI: 10.1371/Journal.Pbio.0000051  0.676
2003 Vogt TM, Blackwell AD, Giannetti AM, Bjorkman PJ, Enns CA. Heterotypic interactions between transferrin receptor and transferrin receptor 2. Blood. 101: 2008-14. PMID 12406888 DOI: 10.1182/Blood-2002-09-2742  0.604
2003 Giannetti AM, Snow PM, Zak O, Björkman PJ. Mechanism for multiple ligand recognition by the human transferrin receptor Plos Biology. 1. DOI: 10.1371/journal.pbio.0000051  0.469
2001 West AP, Giannetti AM, Herr AB, Bennett MJ, Nangiana JS, Pierce JR, Weiner LP, Snow PM, Bjorkman PJ. Mutational analysis of the transferrin receptor reveals overlapping HFE and transferrin binding sites. Journal of Molecular Biology. 313: 385-97. PMID 11800564 DOI: 10.1006/Jmbi.2001.5048  0.604
Low-probability matches (unlikely to be authored by this person)
2008 Tsang E, Giannetti AM, Shaw D, Dinh M, Tse JK, Gandhi S, Ho H, Wang S, Papp E, Bradshaw JM. Molecular mechanism of the Syk activation switch. The Journal of Biological Chemistry. 283: 32650-9. PMID 18818202 DOI: 10.1074/Jbc.M806340200  0.292
2006 Le Pogam S, Kang H, Harris SF, Leveque V, Giannetti AM, Ali S, Jiang WR, Rajyaguru S, Tavares G, Oshiro C, Hendricks T, Klumpp K, Symons J, Browner MF, Cammack N, et al. Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus. Journal of Virology. 80: 6146-54. PMID 16731953 DOI: 10.1128/JVI.02628-05  0.249
2011 Dueber EC, Schoeffler AJ, Lingel A, Elliott JM, Fedorova AV, Giannetti AM, Zobel K, Maurer B, Varfolomeev E, Wu P, Wallweber HJ, Hymowitz SG, Deshayes K, Vucic D, Fairbrother WJ. Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination. Science (New York, N.Y.). 334: 376-80. PMID 22021857 DOI: 10.1126/Science.1207862  0.233
2012 Maurer T, Garrenton LS, Oh A, Pitts K, Anderson DJ, Skelton NJ, Fauber BP, Pan B, Malek S, Stokoe D, Ludlam MJ, Bowman KK, Wu J, Giannetti AM, Starovasnik MA, et al. Small-molecule ligands bind to a distinct pocket in Ras and inhibit SOS-mediated nucleotide exchange activity. Proceedings of the National Academy of Sciences of the United States of America. 109: 5299-304. PMID 22431598 DOI: 10.1073/Pnas.1116510109  0.228
2014 Crawford TD, Ndubaku CO, Chen H, Boggs JW, Bravo BJ, Delatorre K, Giannetti AM, Gould SE, Harris SF, Magnuson SR, McNamara E, Murray LJ, Nonomiya J, Sambrone A, Schmidt S, et al. Discovery of selective 4-Amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization. Journal of Medicinal Chemistry. 57: 3484-93. PMID 24673130 DOI: 10.1021/Jm500155B  0.221
2009 Rich RL, Papalia GA, Flynn PJ, Furneisen J, Quinn J, Klein JS, Katsamba PS, Waddell MB, Scott M, Thompson J, Berlier J, Corry S, Baltzinger M, Zeder-Lutz G, Schoenemann A, ... ... Giannetti AM, et al. A global benchmark study using affinity-based biosensors. Analytical Biochemistry. 386: 194-216. PMID 19133223 DOI: 10.1016/J.Ab.2008.11.021  0.219
2014 Murray J, Giannetti AM, Steffek M, Gibbons P, Hearn BR, Cohen F, Tam C, Pozniak C, Bravo B, Lewcock J, Jaishankar P, Ly CQ, Zhao X, Tang Y, Chugha P, et al. Tailoring small molecules for an allosteric site on procaspase-6. Chemmedchem. 9: 73-7, 2. PMID 24259468 DOI: 10.1002/Cmdc.201300424  0.216
2006 Papalia GA, Leavitt S, Bynum MA, Katsamba PS, Wilton R, Qiu H, Steukers M, Wang S, Bindu L, Phogat S, Giannetti AM, Ryan TE, Pudlak VA, Matusiewicz K, Michelson KM, et al. Comparative analysis of 10 small molecules binding to carbonic anhydrase II by different investigators using Biacore technology. Analytical Biochemistry. 359: 94-105. PMID 17007806 DOI: 10.1016/J.Ab.2006.08.021  0.216
2013 Talamas FX, Ao-Ieong G, Brameld KA, Chin E, de Vicente J, Dunn JP, Ghate M, Giannetti AM, Harris SF, Labadie SS, Leveque V, Li J, Lui AS, McCaleb KL, Nájera I, et al. De novo fragment design: a medicinal chemistry approach to fragment-based lead generation. Journal of Medicinal Chemistry. 56: 3115-9. PMID 23509929 DOI: 10.1021/Jm4002605  0.215
2008 Antonysamy SS, Aubol B, Blaney J, Browner MF, Giannetti AM, Harris SF, Hébert N, Hendle J, Hopkins S, Jefferson E, Kissinger C, Leveque V, Marciano D, McGee E, Nájera I, et al. Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18: 2990-5. PMID 18400495 DOI: 10.1016/J.Bmcl.2008.03.056  0.196
2007 Tse JK, Giannetti AM, Bradshaw JM. Thermodynamics of calmodulin trapping by Ca2+/calmodulin-dependent protein kinase II: subpicomolar Kd determined using competition titration calorimetry. Biochemistry. 46: 4017-27. PMID 17352496 DOI: 10.1021/bi700013y  0.18
2014 Haling JR, Sudhamsu J, Yen I, Sideris S, Sandoval W, Phung W, Bravo BJ, Giannetti AM, Peck A, Masselot A, Morales T, Smith D, Brandhuber BJ, Hymowitz SG, Malek S. Structure of the BRAF-MEK complex reveals a kinase activity independent role for BRAF in MAPK signaling. Cancer Cell. 26: 402-13. PMID 25155755 DOI: 10.1016/J.Ccr.2014.07.007  0.162
2008 Papalia GA, Giannetti AM, Arora N, Myszka DG. Thermodynamic characterization of pyrazole and azaindole derivatives binding to p38 mitogen-activated protein kinase using Biacore T100 technology and van't Hoff analysis. Analytical Biochemistry. 383: 255-64. PMID 18774767 DOI: 10.1016/j.ab.2008.08.010  0.161
2013 Dragovich PS, Fauber BP, Corson LB, Ding CZ, Eigenbrot C, Ge H, Giannetti AM, Hunsaker T, Labadie S, Liu Y, Malek S, Pan B, Peterson D, Pitts K, Purkey HE, et al. Identification of substituted 2-thio-6-oxo-1,6-dihydropyrimidines as inhibitors of human lactate dehydrogenase. Bioorganic & Medicinal Chemistry Letters. 23: 3186-94. PMID 23628333 DOI: 10.1016/J.Bmcl.2013.04.001  0.155
2011 Di Paolo JA, Huang T, Balazs M, Barbosa J, Barck KH, Bravo BJ, Carano RA, Darrow J, Davies DR, DeForge LE, Diehl L, Ferrando R, Gallion SL, Giannetti AM, Gribling P, et al. Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis. Nature Chemical Biology. 7: 41-50. PMID 21113169 DOI: 10.1038/Nchembio.481  0.145
2009 Teotico DG, Babaoglu K, Rocklin GJ, Ferreira RS, Giannetti AM, Shoichet BK. Docking for fragment inhibitors of AmpC beta-lactamase. Proceedings of the National Academy of Sciences of the United States of America. 106: 7455-60. PMID 19416920 DOI: 10.1073/Pnas.0813029106  0.139
2014 Dragovich PS, Fauber BP, Boggs J, Chen J, Corson LB, Ding CZ, Eigenbrot C, Ge H, Giannetti AM, Hunsaker T, Labadie S, Li C, Liu Y, Liu Y, Ma S, et al. Identification of substituted 3-hydroxy-2-mercaptocyclohex-2-enones as potent inhibitors of human lactate dehydrogenase. Bioorganic & Medicinal Chemistry Letters. 24: 3764-71. PMID 25037916 DOI: 10.1016/J.Bmcl.2014.06.076  0.136
2012 Heise CE, Murray J, Augustyn KE, Bravo B, Chugha P, Cohen F, Giannetti AM, Gibbons P, Hannoush RN, Hearn BR, Jaishankar P, Ly CQ, Shah K, Stanger K, Steffek M, et al. Mechanistic and structural understanding of uncompetitive inhibitors of caspase-6. Plos One. 7: e50864. PMID 23227217 DOI: 10.1371/Journal.Pone.0050864  0.101
2014 Phillips AH, Schoeffler AJ, Matsui T, Weiss TM, Blankenship JW, Zobel K, Giannetti AM, Dueber EC, Fairbrother WJ. Internal motions prime cIAP1 for rapid activation. Nature Structural & Molecular Biology. 21: 1068-74. PMID 25383668 DOI: 10.1016/J.Bpj.2013.11.1490  0.098
2013 Fauber BP, Dragovich PS, Chen J, Corson LB, Ding CZ, Eigenbrot C, Giannetti AM, Hunsaker T, Labadie S, Liu Y, Liu Y, Malek S, Peterson D, Pitts K, Sideris S, et al. Identification of 2-amino-5-aryl-pyrazines as inhibitors of human lactate dehydrogenase. Bioorganic & Medicinal Chemistry Letters. 23: 5533-9. PMID 24012183 DOI: 10.1016/J.Bmcl.2013.08.060  0.097
2014 Giannetti AM, Zheng X, Skelton NJ, Wang W, Bravo BJ, Bair KW, Baumeister T, Cheng E, Crocker L, Feng Y, Gunzner-Toste J, Ho YC, Hua R, Liederer BM, Liu Y, et al. Fragment-based identification of amides derived from trans-2-(pyridin-3-yl)cyclopropanecarboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). Journal of Medicinal Chemistry. 57: 770-92. PMID 24405419 DOI: 10.1021/Jm4015108  0.091
2014 Wang L, Stanley M, Boggs JW, Crawford TD, Bravo BJ, Giannetti AM, Harris SF, Magnuson SR, Nonomiya J, Schmidt S, Wu P, Ye W, Gould SE, Murray LJ, Ndubaku CO, et al. Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors. Bioorganic & Medicinal Chemistry Letters. 24: 4546-52. PMID 25139565 DOI: 10.1016/J.Bmcl.2014.07.071  0.09
2014 Dragovich PS, Zhao G, Baumeister T, Bravo B, Giannetti AM, Ho YC, Hua R, Li G, Liang X, Ma X, O'Brien T, Oh A, Skelton NJ, Wang C, Wang W, et al. Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). Bioorganic & Medicinal Chemistry Letters. 24: 954-62. PMID 24433859 DOI: 10.1016/J.Bmcl.2013.12.062  0.074
1997 Giannetti AM, Lindwall GA, Chau M. The fiber forming protein tau and its role in protein folding diseases Faseb Journal. 11: A974.  0.074
2008 Sweeney ZK, Acharya S, Briggs A, Dunn JP, Elworthy TR, Fretland J, Giannetti AM, Heilek G, Li Y, Kaiser AC, Martin M, Saito YD, Smith M, Suh JM, Swallow S, et al. Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase. Bioorganic & Medicinal Chemistry Letters. 18: 4348-51. PMID 18625554 DOI: 10.1016/j.bmcl.2008.06.080  0.073
2008 Giannetti AM, Koch BD, Browner MF. Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors. Journal of Medicinal Chemistry. 51: 574-80. PMID 18181566 DOI: 10.1021/jm700952v  0.057
2011 Giannetti AM. From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance. Methods in Enzymology. 493: 169-218. PMID 21371592 DOI: 10.1016/B978-0-12-381274-2.00008-X  0.057
2000 Giannetti AM, Lindwall G, Chau MF, Radeke MJ, Feinstein SC, Kohlstaedt LA. Fibers of tau fragments, but not full length tau, exhibit a cross beta-structure: implications for the formation of paired helical filaments. Protein Science : a Publication of the Protein Society. 9: 2427-35. PMID 11206064 DOI: 10.1110/ps.9.12.2427  0.054
2015 Giannetti AM, Gilbert HN, Huddler DP, Reiter M, Strande C, Pitts KE, Bravo BJ. Getting the most value from your screens: Advances in hardware, software, and methodologies to enhance surface plasmon resonance based fragment screening and hit-to-lead support Rsc Drug Discovery Series. 2015: 19-48.  0.044
2015 Gobbi A, Giannetti AM, Chen H, Lee ML. Atom-Atom-Path similarity and Sphere Exclusion clustering: tools for prioritizing fragment hits. Journal of Cheminformatics. 7: 11. PMID 25866564 DOI: 10.1186/s13321-015-0056-8  0.038
2020 Chen P, Mar Z, Giannetti A, Hughes S, Gilbert J, Zhao F. An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding. Hospital Pharmacy. 57: 69-75. PMID 35521008 DOI: 10.1177/0018578720973885  0.016
Hide low-probability matches.